ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0804

Incidence and Risk Factors of Active Tuberculosis in Patients with Rheumatic Diseases Complicated with Tuberculosis Infection: A Multicenter Prospective Cohort Study

Lifan Zhang1, yuchen liu2, xiaoqing zou3, shi chen2, yanan ma2, huimin ma4, qifei cao4, zhengrong yang4, Fengchun ZHANG5, Yan Zhao5, Xiaofeng Zeng6 and Xiaoqing Liu1, 1Division of Infectious Diseases, Department of Internal medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Clinical Epidemiology Unit, Peking Union Medical College, International Clinical Epidemiology Network; Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Division of Infectious Diseases, Department of Internal medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China, 3Division of Infectious Diseases, Department of Internal medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 4Division of Infectious Diseases, Department of Internal medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 5Peking Union Medical College Hospital, Beijing, China, 6Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China

Meeting: ACR Convergence 2022

Keywords: Cohort Study, glucocorticoids, Infection, pulmonary, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Infection-related Rheumatic Disease Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: China remains a high-burden country of both rheumatic disease (RD) and tuberculosis (TB) till today. Patients with RD are considered as a high-risk population of TB, and those complicated with TB infection deserve more attention, while there is no guideline on TB prevention and management for this population. The purpose of this study was to investigate the incidence of active tuberculosis (ATB) in RD patients complicated with TB infection (including both latent tuberculosis infection [LTBI] and previous TB), and to analyze the risk factors of TB reactivation, which help formulating TB prevention and management strategies for patients with RD in China.

Methods: We conducted a multi-centered prospective cohort study. Patients confirmed of RD complicated with TB infection from both outpatient and outpatient department of 13 Grade A tertiary hospital in the eastern, central, and western regions of China from September 2014 to March 2016 were recruited. Baseline demographic characteristics, clinical diagnosis, treatment, and laboratory tests were collected. The incidence of ATB was assessed during followed up. Incidence was estimated by the Kaplan–Meier method, and differences in incidence were evaluated with a log-rank test. Multivariable analyses with the Cox proportional-hazards model were used to explore the risk factors for developing ATB.

Results: 904 patients with RD complicated with TB infection were enrolled in this study. The average age of patients in this cohort was 47±14 (mean±SD) years old, women accounted for 70.8%, patients with rheumatoid arthritis (295/904, 32.6%) and systemic lupus erythematosus (209/904, 23.1%) together accounted for more than 50% of the cohort. The median follow-up time was 72 months. During the 6-year follow-up, 26 cases of ATB occurred. The 1-year ATB incidence rate was 664/100000 (95%CI 244/100000-1439/100000), and the 5-year ATB cumulative incidence rate was 2549/100000 (95%CI 1604/100000 -3834/100000). Multivariable Cox proportional hazard model analysis showed that the maximum glucocorticoids dosage (adjusted HR [aHR]=2.43, 95%CI 1.05-5.62, p=0.039 for 30-60mg/d equivalent prednisone; aHR=4.80, 95%CI 1.49-15.44, p=0.008 for >60mg/d equivalent prednisone) and TB contact (aHR=7.25, 95%CI 2.14-24.54, p=0.001) were independent risk factors for ATB.

Conclusion: Patients with RD complicated with TB infection had a higher risk of developing ATB. The use of medium to high dosage of glucocorticoids and the history of TB exposure might be independent risk factors for developing ATB, in which case TB preventive treatment should be considered.

†: Lifan Zhang and Yuchen Liu contributed equally to this work.

Supporting image 1

Table 1. General characteristics of 904 enrolled patients with rheumatic diseases complicated with TB infection

Supporting image 2

Table 2. Potential risk factors of the incidence of ATB in patients with rheumatic diseases complicated with TB infection
SLE=systemic lupus erythematosus. RA=rheumatoid arthritis. BD=Behcet’s disease. LTBI=latent TB infection. GCs=glucocorticoids. WBC=white blood cell. ALT=glutamic-pyruvic transaminase. ESR=erythrocyte sedimentation rate
*Including Sjogren’s syndrome (SS), systemic sclerosis (SSc), mixed connective tissue disease (MCTD), polymyositis (PM), dermatomyositis (DM), Takayasu arthritis (TA), giant cell arthritis (GCA), polyarteritis nodosa (PAN), granulomatosis with polyangiitis (GPA), microscopic polyarteritis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA)

Supporting image 3

Figure 1. Incidence of ATB in patients with rheumatic diseases complicated with TB infection according to maximum daily dosage of GCs


Disclosures: L. Zhang, None; y. liu, None; x. zou, None; s. chen, None; y. ma, None; h. ma, None; q. cao, None; z. yang, None; F. ZHANG, None; Y. Zhao, None; X. Zeng, None; X. Liu, None.

To cite this abstract in AMA style:

Zhang L, liu y, zou x, chen s, ma y, ma h, cao q, yang z, ZHANG F, Zhao Y, Zeng X, Liu X. Incidence and Risk Factors of Active Tuberculosis in Patients with Rheumatic Diseases Complicated with Tuberculosis Infection: A Multicenter Prospective Cohort Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/incidence-and-risk-factors-of-active-tuberculosis-in-patients-with-rheumatic-diseases-complicated-with-tuberculosis-infection-a-multicenter-prospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-and-risk-factors-of-active-tuberculosis-in-patients-with-rheumatic-diseases-complicated-with-tuberculosis-infection-a-multicenter-prospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology